{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T14:33:48Z","timestamp":1768314828211,"version":"3.49.0"},"reference-count":31,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,8,19]],"date-time":"2022-08-19T00:00:00Z","timestamp":1660867200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pediatr."],"abstract":"<jats:p>Lupus podocytopathy is a glomerular lesion in systemic lupus erythematosus (SLE) characterized by diffuse podocyte foot process effacement (FPE) without immune complex (IC) deposition or with only mesangial IC deposition. It is rarely seen in children with SLE. A 13-year-old girl met the 2019 European League Against Rheumatism (EULAR)\/ American College of Rheumatology (ACR) Classification Criteria for SLE based on positive ANA; facial rash; thrombocytopenia; proteinuria; and positive antiphospholipid (aPL) antibodies, including lupus anticoagulant (LAC), anti-\u03b22 glycoprotein-I antibody (anti-\u03b22GPI), and anti-cardiolipin antibody (aCL). The renal lesion was characterized by 3+ proteinuria, a 4.2 mg\/mg spot (random) urine protein to creatinine ratio, and hypoalbuminemia (26.2 g\/l) at the beginning of the disease. Kidney biopsy findings displayed negative immunofluorescence (IF) for immunoglobulin A (IgA), IgM, fibrinogen (Fb), C3, and C1q, except faint IgG; a normal glomerular appearance under a light microscope; and diffuse podocyte foot process effacement (FPE) in the absence of subepithelial or subendothelial deposition by electron microscopy (EM). Histopathology of the epidermis and dermis of the pinna revealed a hyaline thrombus in small vessels. The patient met the APS classification criteria based on microvascular thrombogenesis and persistently positive aPL antibodies. She responded to a combination of glucocorticoids and immunosuppressive agents. Our study reinforces the need to consider the potential cooccurrence of LP and APS. Clinicians should be aware of the potential presence of APS in patients with a diagnosis of LP presenting with NS and positivity for aPL antibodies, especially triple aPL antibodies (LCA, anti-\u03b22GPI, and aCL).<\/jats:p>","DOI":"10.3389\/fped.2022.950576","type":"journal-article","created":{"date-parts":[[2022,8,19]],"date-time":"2022-08-19T06:45:17Z","timestamp":1660891517000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Lupus podocytopathy and antiphospholipid syndrome in a child with SLE: A case report and literature review"],"prefix":"10.3389","volume":"10","author":[{"given":"Guo-min","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi-fan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiao-qian","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-mei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hai-mei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jia-yan","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bing-bing","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,8,19]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1159\/000481633","article-title":"Review of podocyte biology","volume":"47","author":"Garg","year":"2018","journal-title":"Am J Nephrol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1038\/s41572-020-0196-7","article-title":"Podocytopathies","volume":"6","author":"Kopp","year":"2020","journal-title":"Nat Rev Dis Primers."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1016\/j.kint.2016.01.012","article-title":"Podocyte injury and its consequences","volume":"89","author":"Nagata","year":"2016","journal-title":"Kidney Int."},{"key":"B4","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1053\/j.ajkd.2019.12.019","article-title":"Approach to diagnosis and management of primary glomerular diseases due to podocytopathies in adults: core curriculum 2020","volume":"75","author":"Ahn","year":"2020","journal-title":"Am J Kidney Dis."},{"key":"B5","doi-asserted-by":"publisher","first-page":"ITC81","DOI":"10.7326\/AITC202006020","article-title":"Systemic lupus erythematosus","volume":"172","author":"Kiriakidou","year":"2020","journal-title":"Ann Intern Med"},{"key":"B6","doi-asserted-by":"publisher","first-page":"825","DOI":"10.2215\/CJN.05780616","article-title":"Update on lupus nephritis","volume":"12","author":"Almaani","year":"2017","journal-title":"Clin J Am Soc Nephrol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.3390\/jcm8091340","article-title":"Podocyte injury in lupus nephritis","volume":"8","author":"Sakhi","year":"2019","journal-title":"J Clin Med."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.1002\/art.39594","article-title":"Risk of end-stage renal disease in patients with lupus nephritis, 1971\u20132015: a systematic review and bayesian meta-analysis","volume":"68","author":"Tektonidou","year":"2016","journal-title":"Arthritis Rheumatol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"585","DOI":"10.2215\/CJN.06720615","article-title":"Clinical-morphological features and outcomes of lupus podocytopathy","volume":"11","author":"Hu","year":"2016","journal-title":"Clin J Am Soc Nephrol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"547","DOI":"10.2215\/CJN.01880216","article-title":"Lupus podocytopathy: a distinct entity","volume":"11","author":"Bomback","year":"2016","journal-title":"Clin J Am Soc Nephrol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1053\/j.ackd.2019.08.011","article-title":"Lupus podocytopathy: an overview","volume":"26","author":"Oliva-Damaso","year":"2019","journal-title":"Adv Chronic Kidney Dis."},{"key":"B12","doi-asserted-by":"publisher","first-page":"2010","DOI":"10.1056\/NEJMra1705454","article-title":"Diagnosis and management of the antiphospholipid syndrome","volume":"378","author":"Garcia","year":"2018","journal-title":"N Engl J Med."},{"key":"B13","doi-asserted-by":"publisher","first-page":"101463","DOI":"10.1016\/j.berh.2019.101463","article-title":"Antiphospholipid syndrome","volume":"34","author":"Sammaritano","year":"2020","journal-title":"Best Pract Res Clin Rheumatol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1002\/art.40930","article-title":"2019 European league against rheumatism\/American college of rheumatology classification criteria for systemic lupus erythematosus","volume":"71","author":"Aringer","year":"2019","journal-title":"Arthritis Rheumatol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1093\/rheumatology\/kev311","article-title":"The frequency and outcome of lupus nephritis: results from an international inception cohort study","volume":"55","author":"Hanly","year":"2016","journal-title":"Rheumatology."},{"key":"B16","doi-asserted-by":"publisher","first-page":"e001299","DOI":"10.1136\/rmdopen-2020-001299","article-title":"Predictors of renal damage in systemic lupus erythematous patients: data from a multiethnic, multinational Latin American lupus cohort (GLADEL)","volume":"6","author":"Re\u00e1tegui-Sokolova","year":"2020","journal-title":"RMD Open."},{"key":"B17","doi-asserted-by":"publisher","first-page":"v39","DOI":"10.1093\/rheumatology\/keaa381","article-title":"Lupus nephritis: clinical presentations and outcomes in the 21st century","volume":"59","author":"Gasparotto","year":"2020","journal-title":"Rheumatology"},{"key":"B18","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1038\/nrneph.2017.85","article-title":"Redefining lupus nephritis: clinical implications of pathophysiologic subtypes","volume":"13","author":"Yu","year":"2017","journal-title":"Nat Rev Nephrol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1016\/j.kint.2017.11.023","article-title":"Revision of the international society of nephrology\/renal pathology society classification for lupus nephritis: clarification of definitions, and modified National Institutes of Health activity and chronicity indices","volume":"93","author":"Bajema","year":"2018","journal-title":"Kidney Int."},{"key":"B20","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1681\/ASN.2004050350","article-title":"Glomerular podocytopathy in patients with systemic lupus erythematosus","volume":"16","author":"Kraft","year":"2005","journal-title":"J Am Soc Nephrol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s12969-021-00547-9","article-title":"Is podocytopathy another image of renal affection in p-SLE?","volume":"19","author":"Abdelnabi","year":"2021","journal-title":"Pediatr Rheumatol Online J."},{"key":"B22","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1191\/0961203306lu2285cr","article-title":"A case of minimal-change nephrotic syndrome in pediatric lupus erythematosus: just a coincidence?","volume":"15","author":"Wang","year":"2006","journal-title":"Lupus."},{"key":"B23","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1177\/0961203311432740","article-title":"A case of steroid-resistant nephrotic syndrome associated with systemic lupus erythematosus","volume":"23","author":"Ito","year":"2014","journal-title":"Lupus."},{"key":"B24","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1177\/0961203318817831","article-title":"Chylous ascites and podocytopathy as the presentation of childhood lupus-an unusual occurrence","volume":"28","author":"Pilania","year":"2019","journal-title":"Lupus."},{"key":"B25","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.trsl.2020.04.006","article-title":"Antiphospholipid syndrome","volume":"225","author":"Petri","year":"2020","journal-title":"Transl Res."},{"key":"B26","first-page":"2214","article-title":"Association between antiphospholipid antibodies and recurrent fetal loss in women without autoimmune disease: a metaanalysis","volume":"33","author":"Opatrny","year":"2006","journal-title":"J Rheumatol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1177\/0961203307079036","article-title":"Antiphospholipid antibodies in pediatric systemic lupus erythematosus and the antiphospholipid syndrome","volume":"16","author":"Avcin","year":"2007","journal-title":"Lupus"},{"key":"B28","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.3389\/fimmu.2018.01008","article-title":"Renal Involvement in Antiphospholipid Syndrome","volume":"9","author":"Turrent-Carriles","year":"2018","journal-title":"Front Immunol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.kint.2016.06.026","article-title":"Antiphospholipid syndrome and kidney disease","volume":"91","author":"Bienaim\u00e9","year":"2017","journal-title":"Kidney Int."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.3389\/fimmu.2018.01181","article-title":"Antiphospholipid syndrome nephropathy: from pathogenesis to treatment","volume":"9","author":"Tektonidou","year":"2018","journal-title":"Front Immunol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"6746473","DOI":"10.1155\/2018\/6746473","article-title":"Is It Coincidence or consequence for a case with antiphospholipid antibody syndrome overlapping sle to develop an immune complex nephropathy followed by a nonimmune complex podocytopathy?","volume":"2018","author":"Yoo","year":"2018","journal-title":"Case Rep Nephrol."}],"container-title":["Frontiers in Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2022.950576\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,19]],"date-time":"2022-08-19T06:45:20Z","timestamp":1660891520000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2022.950576\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,19]]},"references-count":31,"alternative-id":["10.3389\/fped.2022.950576"],"URL":"https:\/\/doi.org\/10.3389\/fped.2022.950576","relation":{},"ISSN":["2296-2360"],"issn-type":[{"value":"2296-2360","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,19]]},"article-number":"950576"}}